Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBTA9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,549
Award facts
- Contract value 100% obligated
- $25,549.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,549.20 to AmerisourceBergen Drug Corp for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes on January 6, 2026. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for adult immunization, representing the type of critical pharmaceutical and medical supply that supports military healthcare operations globally.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. AmerisourceBergen's consistent performance across multiple pharmaceutical delivery orders demonstrates its established capability to efficiently fulfill government contracts for essential medical commodities required by military treatment facilities and veterans' healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FBTA9?
SPE2DR26FBTA9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FBTA9 worth?
The government has obligated $25,549 on SPE2DR26FBTA9.
Is contract SPE2DR26FBTA9 an order under another contract?
Yes. SPE2DR26FBTA9 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBTA9 competed?
The extent of competition for SPE2DR26FBTA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award